Glycosaminoglycans may help postpone peritoneal failure in long-term continuous ambulatory peritoneal dialysis (CAPD)
This article was originally published in Clinica
Executive Summary
Administering glycosaminoglycans to patients on long-term continuous ambulatory peritoneal dialysis (CAPD) may help maintain the efficiency of the treatment, say Italian researchers in the Lancet (September 16th). Previous observations had shown that glycosaminoglycans have a protective effect on peritoneal structure and function in diabetic and other experimental rats.